Amlodipine Besylate; Perindopril Arginine Patent Expiration
Amlodipine Besylate; Perindopril Arginine is Used for treating high blood pressure. It was first introduced by Adhera Therapeutics Inc
Amlodipine Besylate; Perindopril Arginine Patents
Given below is the list of patents protecting Amlodipine Besylate; Perindopril Arginine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prestalia | US7846961 | α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | Oct 05, 2029 | Adhera |
| Prestalia | US6696481 | Salt of perindopril and pharmaceutical compositions containing it |
Apr 15, 2023
(Expired) | Adhera |
Amlodipine Besylate; Perindopril Arginine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List